We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
£1.2 million in government funding will help researchers develop an innovative online programme to improve and personalise care for people with dementia in care homes, which were hard-hit by the COVID-19 crisis.
By NIHR Maudsley BRC at 7 Oct 2020An online study of 25,000 people is recruiting participants to help study the impact of COVID-19 isolation on the health and wellbeing of older people, and find new ways to support them.
By NIHR Maudsley BRC at 15 May 2020Researchers from the NIHR Maudsley BRC are to lead a pioneering new study into a cannabis-based treatment for people living with dementia. Alzheimer’s Research UK has awarded over £250,000 for the landmark phase II clinical trial of Sativex®, a cannabis-based medicine licenced in the UK. The drug has already been found to be safe in people and has been approved for use in the treatment of muscle stiffness and tightness experienced by people with multiple sclerosis. However, Sativex® is not currently licensed in the UK for any other indication, including treatment of the symptoms of dementia.
By NIHR Maudsley BRC at 21 Feb 2019
Several of our researchers led an exploration of sensitive issues raised by a production of Florian Zeller’s The Father, at South London Theatre in West Norwood on Wednesday 6 February. The Q&A session was chaired by the BRC’s Engagement and Impact Fellow, Dr Sally Marlow, and featured Rob Stewart, Professor of Psychiatric Epidemiology and Clinical Informatics, who also leads the BRC’s Informatics cluster.
By NIHR Maudsley BRC at 11 Feb 2019Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
By NIHR Maudsley BRC at 20 Nov 2018
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
